Invesco Ltd.

Position in AVTX — Avalo Therapeutics, Inc.

CIK 914208 Atlanta, GA

Position in AVTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$410,736

+$396,836 QoQ

Shares Held

22,226

+317414.3% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#91

of 126 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 0% Shared 95% None 5%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. AVTX ranks #196 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$410,736	22,226	+15.9%	Shares	Defined	2026-08-14
2022-03-31	$13,900	19,173	-1.2%	Shares	Defined	2022-05-16
2021-12-31	$32,988	19,405	+3.5%	Shares	Defined	2022-02-14
2021-09-30	$40,872	18,749	—	Shares	Defined	2021-11-15
2021-06-30 CERC	—	13,883	-45.0%	Shares	Defined	2021-08-17
2021-03-31 CERC	—	25,219	-6.4%	Shares	Defined	2021-05-17
2020-12-31 CERC	—	26,946	-32.4%	Shares	Defined	2021-02-16
2020-09-30 CERC	—	39,840	-44.9%	Shares	Defined	2020-11-16
2020-06-30 CERC	—	72,279	+20.5%	Shares	Defined	2020-08-14
2020-03-31 CERC	—	59,979	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.